Hematologist
CION Cancer Clinics
Long-term monitoring after CAR-T: what to expect | CION Cancer Clinics
Follow-up after CAR-T lasts for years. Expect frequent blood tests, antibody checks and response scans in the first months, spacing out after the first year but never stopping. The team is watching blood counts, your defence against infection, rare late effects and whether the disease stays away. This page explains what each check is for, how shared care near home works, and which symptoms need same-day help. At CION Cancer Clinics, our haematology team assesses whether a transplant or CAR-T fits your situation and coordinates care with qualified centres.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does follow-up after CAR-T actually involve?
- How often will you be seen, and how does that change?
- What is actually being checked?
- Which words will you see on follow-up reports?
- How do you manage follow-up from a district far from the centre?
- What do families often get wrong about follow-up?
- Common questions about monitoring after CAR-T
The short answer
What does follow-up after CAR-T actually involve?
Follow-up after CAR-T means regular blood tests, clinic reviews and occasional scans for years, not weeks. Visits are closest together in the first few months and space out as your blood counts and immune system settle.
Why the checks go on for so long
CAR-T cells are your own immune cells, changed in a laboratory and given back to you. Some of them can stay in the body for a long time. That is part of how the treatment works, and it is also why the team keeps watching. The things that need tracking are slow: blood counts that take months to recover, a weaker defence against infection, and the question of whether the blood cancer stays away.
Who does the checking
The centre that gave the CAR-T usually leads the first months. After that, many people move to shared care. A haematologist nearer home does the routine tests and sends the results back to the treating centre. For a family in Warangal, Nizamabad or Kurnool, that can save a long journey every fortnight. It works only when both teams talk to each other, so ask at discharge who is responsible for what.
This page describes a typical pattern. Your own schedule comes from your treating team and may be quite different.The pattern over time
How often will you be seen, and how does that change?
A typical shape, not a rule. Every treating centre sets its own schedule.
-
The first weeks after the infusion
You stay close to the treating centre and are checked very often. The team is watching for fever, a drop in blood pressure and confusion, the early reactions CAR-T can cause. You will be advised not to drive for several weeks, because confusion can appear late.
-
The first few months
Visits move to roughly weekly, then fortnightly. Each one usually means a full blood count, an antibody level and a check for infection. The first look at whether the disease has responded happens in this period, often with a PET-CT for lymphoma or a bone marrow test for leukaemia and myeloma.
-
The rest of the first year
Visits space out to monthly or every few months. The team checks whether counts are climbing back, whether antibody levels need topping up, and when vaccines can safely start again.
-
After the first year
Reviews become less frequent but do not stop. The focus shifts to late effects: repeated infections, new cancers, heart and hormone changes, and whether the original disease has come back.
-
The long tail
Regulators ask that people who had CAR-T are followed for many years, partly to learn about rare late effects. Keep the treating centre informed even if you move house or change doctors.
Not sure whether this applies to you?
Ask an oncologistAt each visit
What is actually being checked?
Most visits are short. The work is in the results, which your team reads against your earlier ones rather than on their own.
Blood counts
White cells, platelets and haemoglobin can stay low for months after CAR-T, or dip again after an early recovery. Some people need transfusions or injections to lift the white cell count for a while.
Reference ranges differ between laboratories. One result is read alongside your symptoms and repeat tests.Your defence against infection
CAR-T for most blood cancers also removes the healthy B cells that make antibodies. The team measures your antibody level, called IgG, and decides whether you need replacement antibodies through a drip.
Whether the disease stays away
Response is checked at set points, then less often.
Usually by
- PET-CT for lymphoma
- Bone marrow test for leukaemia
- Blood and urine protein tests for myeloma
Late effects
New cancers are uncommon but are watched for, including rare cancers of T cells that regulators have asked centres to report. Heart, thyroid, memory and fertility are reviewed as the years go on.
!
What cannot wait for the next visit
After CAR-T, a fever, shivering, new confusion, trouble speaking, shaking, severe breathlessness or unusual bleeding needs care the same day. Call your treating centre's emergency number at once. If you cannot reach them, go to the nearest emergency department or call 108, and tell them you have had CAR-T cell therapy. Carry the wallet card from your treating centre everywhere.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your reports
Which words will you see on follow-up reports?
- Cytopenia
- A low count of one or more types of blood cell. After CAR-T it can last for months.
- B-cell aplasia
- Your body is not making B cells, the cells that make antibodies. It is an expected effect of most CAR-T for blood cancers.
- IgG
- The main antibody in the blood. A low level means a weaker defence against infection.
- MRD (measurable residual disease)
- A very sensitive test for cancer cells too few to see under an ordinary microscope.
- CAR-T persistence
- Whether the changed cells can still be found in your blood. It is a research-style test and not done everywhere.
Living far away
How do you manage follow-up from a district far from the centre?
Ask for a written follow-up plan before you leave the treating centre. It should list which tests are due, how often, who orders them and where the results go. Without it, the local laboratory and the treating centre each assume the other is watching.
Keep one folder, and take it everywhere
Put the discharge summary, the name of the CAR-T product, every blood report and every scan report in date order. When a local doctor sees you for a cough or a fever, that folder tells them in a minute what would take an hour to explain.
What CION's haematology team can do
CION does not give CAR-T itself. What our haematology team can do is review your reports, run routine follow-up tests closer to home, present your case at a tumour board if something changes, and coordinate with your treating centre. Ask your treating centre whether they are comfortable with that shared arrangement before you rely on it.
What this page cannot tell you
It cannot tell you how long your response will last, or what your own results mean. Those answers depend on your disease, the product you had and how your body has recovered. Only your treating haematologist can read them together.
Commonly believed
What do families often get wrong about follow-up?
"The scan was clear, so the visits do not matter any more."
A clear scan is good news about the disease. It says nothing about your antibody levels, your blood counts or your risk of infection, which are what most follow-up visits are really checking. Missing them is how a treatable infection turns into an admission.
"His counts are still low, so the CAR-T has failed."
Low counts for months are common after CAR-T and are not, on their own, a sign that the treatment has not worked. Whether the disease has responded is judged by scans, marrow tests or protein tests, not by the blood count.
"The local doctor does not need to know about the CAR-T."
They need to know every time. An ordinary-looking fever means something very different after CAR-T. Show the wallet card and the discharge summary at every visit, even for something that seems unrelated.
"She feels well now, so the antibiotic tablets can stop."
Preventive medicines after CAR-T are given because the immune system is weak, not because you feel ill. Feeling well is the point of them. Never stop, skip or change one on your own. Ask the treating team at your next review.
Questions we are asked
Common questions about monitoring after CAR-T
How long will follow-up after CAR-T go on?
For many years. Visits are frequent in the first months and space out after the first year, but they do not stop. Part of the reason is to look after you, and part is that regulators ask centres to track rare late effects over a long time. Your treating centre will tell you its own schedule.
Can the follow-up tests be done in Hyderabad or near home?
Often the routine ones can, once the first few months are over. Blood counts and antibody levels can be checked at a laboratory nearer home, with results sent to the treating centre. Response scans and marrow tests are usually arranged by the treating team. Agree the plan with them in writing first.
Why are my blood counts still low months later?
Low counts that last for months, or come back after an early recovery, are a known effect of CAR-T. The reasons are not fully understood. Your team may use transfusions or injections to support the counts while the marrow recovers. Ask what they are watching for and when they would investigate further.
When can I have my vaccines again?
Your treating team decides, usually once your immune system has started to recover. Some vaccines can be given earlier than others. Live vaccines are generally avoided for longer. Do not take any vaccine, including one offered at a camp or pharmacy, without checking with the team first.
What does a raised or low IgG on my report mean?
IgG is the main antibody in your blood. A low level after CAR-T usually reflects the loss of B cells, and it means you are more open to chest and sinus infections. Whether it needs replacing depends on the level, your infections and your team's policy, not on the number alone.
Is there a risk of a new cancer after CAR-T?
New cancers after CAR-T are uncommon, but they are watched for, including rare cancers of T cells that regulators have asked centres to report. Many people have also had earlier chemotherapy, which carries its own risk. Report any new lump, rash or lasting symptom at your next visit.
Can I travel or go back to work?
Many people return to work and travel once the early months are over and counts have recovered. Driving is restricted for a period after the infusion. Crowded places, long journeys and jobs with infection risk need a conversation with your team first, especially while antibody levels are low.
Does follow-up cost a lot, and do schemes cover it?
Routine blood tests are modest, but scans, marrow tests and antibody replacement add up over a year. Coverage under Aarogyasri, PM-JAY, CGHS, ECHS, EHS or cashless insurance depends on the scheme and changes over time, so check the current rules. Call the helpline and we will help you check your cover.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- American Cancer Society — CAR T-cell Therapy and Its Side Effects
- National Cancer Institute — CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers
- Cancer Research UK — CAR T-cell therapy
- Cancer.Net — What is CAR T-cell therapy?
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
B-Cell Aplasia and Immunoglobulin Replacement After CAR-TWhy antibody levels fall and when replacement is givenRelapse After CAR-TWhat happens if follow-up finds the disease has returnedStaying Near the Centre After CAR-T InfusionThe first weeks before follow-up moves closer to homePET-CT scan guideThe scan often used to check response in lymphomaCAR-T: The GapsEvery stage of CAR-T, from referral to follow-up
Talk to us
Living far from your CAR-T centre?
Tell us what has been done so far. Our haematology team can review your reports and help you plan follow-up closer to home with your treating centre. One helpline serves every CION centre.